Cargando…
Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19?
Using an international setting consisting of 5410 corporations domiciled in 24 countries, we test the insurance-like effect of corporate social responsibility (CSR) performance in the era of the pandemic and confirm that CSR performance increases socially responsible companies’ resilience against th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889246/ https://www.ncbi.nlm.nih.gov/pubmed/36743218 http://dx.doi.org/10.1007/s10551-023-05331-1 |
_version_ | 1784880690041454592 |
---|---|
author | Poursoleyman, Ehsan Mansourfar, Gholamreza Hassan, Mohammad Kabir Homayoun, Saeid |
author_facet | Poursoleyman, Ehsan Mansourfar, Gholamreza Hassan, Mohammad Kabir Homayoun, Saeid |
author_sort | Poursoleyman, Ehsan |
collection | PubMed |
description | Using an international setting consisting of 5410 corporations domiciled in 24 countries, we test the insurance-like effect of corporate social responsibility (CSR) performance in the era of the pandemic and confirm that CSR performance increases socially responsible companies’ resilience against the adverse effects of the crisis. Comparing stakeholders' responses to CSR activities during the pandemic and normal periods, we observe that the link between CSR performance and firm value is stronger during the crisis period. We also realize that the social aspect of CSR performance is the main driver for the mentioned effects. Finally, comparing the resilience of highly committed socially responsible companies with those with moderate and very low CSR ratings, we observe that best-in-class companies enjoy the greatest buffering effects, implying that the insurance-like effect of CSR performance is non-linear against systematic crises. Findings are robust to ceremonial CSR activities, extreme values of market-based instruments, endogeneity concern, etc. |
format | Online Article Text |
id | pubmed-9889246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-98892462023-02-01 Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19? Poursoleyman, Ehsan Mansourfar, Gholamreza Hassan, Mohammad Kabir Homayoun, Saeid J Bus Ethics Original Paper Using an international setting consisting of 5410 corporations domiciled in 24 countries, we test the insurance-like effect of corporate social responsibility (CSR) performance in the era of the pandemic and confirm that CSR performance increases socially responsible companies’ resilience against the adverse effects of the crisis. Comparing stakeholders' responses to CSR activities during the pandemic and normal periods, we observe that the link between CSR performance and firm value is stronger during the crisis period. We also realize that the social aspect of CSR performance is the main driver for the mentioned effects. Finally, comparing the resilience of highly committed socially responsible companies with those with moderate and very low CSR ratings, we observe that best-in-class companies enjoy the greatest buffering effects, implying that the insurance-like effect of CSR performance is non-linear against systematic crises. Findings are robust to ceremonial CSR activities, extreme values of market-based instruments, endogeneity concern, etc. Springer Netherlands 2023-02-01 /pmc/articles/PMC9889246/ /pubmed/36743218 http://dx.doi.org/10.1007/s10551-023-05331-1 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Poursoleyman, Ehsan Mansourfar, Gholamreza Hassan, Mohammad Kabir Homayoun, Saeid Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19? |
title | Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19? |
title_full | Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19? |
title_fullStr | Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19? |
title_full_unstemmed | Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19? |
title_short | Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19? |
title_sort | did corporate social responsibility vaccinate corporations against covid-19? |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889246/ https://www.ncbi.nlm.nih.gov/pubmed/36743218 http://dx.doi.org/10.1007/s10551-023-05331-1 |
work_keys_str_mv | AT poursoleymanehsan didcorporatesocialresponsibilityvaccinatecorporationsagainstcovid19 AT mansourfargholamreza didcorporatesocialresponsibilityvaccinatecorporationsagainstcovid19 AT hassanmohammadkabir didcorporatesocialresponsibilityvaccinatecorporationsagainstcovid19 AT homayounsaeid didcorporatesocialresponsibilityvaccinatecorporationsagainstcovid19 |